FDA oversight : blood safety and the implications of pool sizes in the manufacture of plasma derivatives : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, July 31, 1997.
1998
KF27 .G663 1997i
Available at Government Documents Microfiche
Items
Details
Title
FDA oversight : blood safety and the implications of pool sizes in the manufacture of plasma derivatives : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, July 31, 1997.
Corporate Author
United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources.
ISBN
0160561035
Publication Details
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1998.
Language
English
Description
iii, 427 p. : ill. ; 24 cm.
Call Number
KF27 .G663 1997i
GPO Item No.
1016-A
1016-B (MF)
1016-B (MF)
Note
Distributed to some depository libraries in microfiche.
Shipping list no.: 98-0150-P.
"Serial no. 105-70."
Shipping list no.: 98-0150-P.
"Serial no. 105-70."
Bibliography, etc. Note
Includes bibliographical references.
Record Appears in
On-Campus Resources > Government Resources
All Resources
All Resources